New documents have investigators questioning inconsistencies and omissions in data reporting in the PLATO trial, building on ...
Tracer Biotechnologies, a next-generation diagnostics company, today announced a multi-year project with AstraZeneca (LSE/STO/Nasdaq: AZN). The agreement will enable AstraZeneca to use Tracer's ...
We are seeing exciting data across our research programs, including in two ongoing studies with AstraZeneca and Merck. The fact that world-class organizations and government bodies are willing to fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback